Country Profile

Albania

Albania is a developing market for Indian pharmaceuticals — $2.36M in FY 2025–26, with 4.1× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $93K. The compound annual growth rate since FY2015 stands at 13.6%.

🇦🇱 $2.36M · 4.1× growth since FY2015 · 13.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$2.36M
Exports FY2025–26 DGCIS
4.1×
Growth FY2015→2026
13.6%
CAGR FY2015→2026
87%
Medicines Share
5
Product Categories Supplied
Albania is a developing market for Indian pharmaceuticals — $2.36M in FY 2025–26, with 4.1× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $93K. The compound annual growth rate since FY2015 stands at 13.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $2.06M (87.5%) Surgical & Hospital Supplies $94K (4.0%) Vaccines $93K (3.9%) Medicine Ingredients $87K (3.7%) Traditional & Herbal $22K (0.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Albania in the RBI overseas direct investment dataset (2011–2026).